Total Payments
$1,890
2024 Payments
$143.49
Companies
32
Transactions
94
Medicare Patients
4,340
Medicare Billing
$317,478
Payment Breakdown by Category
Food & Beverage$1,890 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,890 | 94 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $236.42 | 9 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $218.61 | 12 | $0 (2020) |
| Stryker Corporation | $148.85 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $129.30 | 7 | $0 (2021) |
| Celgene Corporation | $128.37 | 7 | $0 (2019) |
| Dilon Technologies, Inc. | $121.47 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $104.52 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $84.52 | 6 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $69.61 | 4 | $0 (2020) |
| Lilly USA, LLC | $65.12 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.49 | 2 | Dilon Technologies, Inc. ($121.47) |
| 2021 | $51.61 | 2 | Janssen Biotech, Inc. ($29.21) |
| 2020 | $109.23 | 7 | Novartis Pharmaceuticals Corporation ($23.66) |
| 2019 | $485.01 | 21 | Stryker Corporation ($148.85) |
| 2018 | $349.29 | 22 | Celgene Corporation ($75.83) |
| 2017 | $751.85 | 40 | Genentech USA, Inc. ($192.40) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Ethicon US, LLC | ETHICON (Device), SURGICEL NU-KNIT, SURGICEL NU-KNIT | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Biosurgical | ||||||
| 02/29/2024 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $121.47 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 10/25/2021 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Oncology | ||||||
| 06/04/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Oncology | ||||||
| 10/20/2020 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Oncology | ||||||
| 08/03/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2020 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Hematology | ||||||
| 03/11/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Oncology | ||||||
| 03/06/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 02/26/2020 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: ONCOLOGY | ||||||
| 02/10/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Oncology | ||||||
| 12/09/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $51.71 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/19/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Oncology | ||||||
| 11/15/2019 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: BioOncology | ||||||
| 11/13/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Hematology / Oncology | ||||||
| 10/16/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: Oncology | ||||||
| 09/27/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Oncology | ||||||
| 08/23/2019 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Oncology | ||||||
| 08/21/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Oncology | ||||||
| 08/16/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: Cardiovascular | ||||||
| 08/14/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2019 | Stryker Corporation | SURG - NEPTUNE (Device) | Food and Beverage | Cash or cash equivalent | $116.37 | General |
| Category: SURGICAL | ||||||
| 07/17/2019 | Stryker Corporation | SURG - NEPTUNE (Device) | Food and Beverage | Cash or cash equivalent | $32.48 | General |
| Category: SURGICAL | ||||||
| 03/07/2019 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Oncology | ||||||
| 02/18/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,554 | 3,612 | $787,328 | $214,714 |
| 2022 | 8 | 223 | 240 | $79,680 | $30,487 |
| 2021 | 7 | 238 | 266 | $91,400 | $33,292 |
| 2020 | 11 | 325 | 341 | $130,623 | $38,986 |
Total Patients
4,340
Total Services
4,459
Medicare Billing
$317,478
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 1,175 | 1,175 | $329,115 | $100,038 | 30.4% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 1,175 | 1,175 | $88,215 | $25,991 | 29.5% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 213 | 213 | $97,340 | $15,203 | 15.6% |
| 19301 | Partial removal of breast | Facility | 2023 | 30 | 31 | $40,513 | $14,361 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 164 | $24,160 | $10,209 | 42.3% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 133 | 151 | $40,015 | $9,654 | 24.1% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 113 | 115 | $38,525 | $8,973 | 23.3% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 207 | 216 | $39,270 | $8,629 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 42 | $12,000 | $5,633 | 46.9% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 220 | 228 | $37,620 | $3,856 | 10.2% |
| 38525 | Biopsy or removal of deep lymph nodes of underarm | Facility | 2023 | 22 | 22 | $18,890 | $3,790 | 20.1% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 23 | 23 | $6,440 | $2,454 | 38.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $6,830 | $2,412 | 35.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,370 | $1,866 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $3,050 | $1,274 | 41.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 12 | 15 | $975.00 | $373.05 | 38.3% |
| 19301 | Partial removal of breast | Facility | 2022 | 19 | 22 | $27,610 | $11,096 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 120 | $16,800 | $7,950 | 47.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $7,410 | $2,616 | 35.3% |
| 38525 | Biopsy or removal of deep lymph nodes of underarm | Facility | 2022 | 14 | 14 | $11,830 | $2,288 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 20 | $4,100 | $1,917 | 46.8% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 17 | 17 | $4,760 | $1,759 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,095 | $1,632 | 39.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $3,075 | $1,229 | 40.0% |
| 19301 | Partial removal of breast | Facility | 2021 | 21 | 21 | $26,355 | $9,473 | 35.9% |
About Dr. Krista Bott, M.D
Dr. Krista Bott, M.D is a Surgery healthcare provider based in Stroudsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1104051200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krista Bott, M.D has received a total of $1,890 in payments from pharmaceutical and medical device companies, with $143.49 received in 2024. These payments were reported across 94 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($1,890).
As a Medicare-enrolled provider, Bott has provided services to 4,340 Medicare beneficiaries, totaling 4,459 services with total Medicare billing of $317,478. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Surgery
- Location Stroudsburg, PA
- Active Since 05/19/2009
- Last Updated 05/04/2023
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1104051200
Products in Payments
- Perjeta (Biological) $195.75
- SURG - NEPTUNE (Device) $148.85
- HEMOBLAST BELLOWS (Device) $121.47
- AFINITOR (Drug) $81.08
- KISQALI (Drug) $77.02
- KEYTRUDA (Biological) $71.87
- DARZALEX (Biological) $67.15
- Revlimid (Drug) $66.13
- IMBRUVICA (Drug) $62.15
- TASIGNA (Drug) $60.51
- CYRAMZA (Drug) $54.29
- Xofigo (Drug) $52.36
- FLEXITOUCH (Device) $51.71
- OPDIVO (Biological) $46.81
- ELIQUIS (Drug) $41.27
- Abraxane (Drug) $38.44
- Nplate (Biological) $37.17
- PADCEV (Biological) $34.73
- Halaven (Drug) $34.02
- Lonsurf (Drug) $33.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.